News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
News|Videos|February 11, 2017

The Concept and Reality of Precision Medicine

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Oya Gilbert

Advice for Patients Newly Diagnosed With Multiple Myeloma

ByOya Gilbert
December 27th 2025
image of man.

A Five-Time Cancer Survivor’s Advice for Patients

ByBill Potts
December 27th 2025
Orserdu plus Verzenio or Afinitor was well tolerated and showed early signs of effectiveness in advanced ER+/HER2– breast cancer: © stock.adobe.com.

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

ByCourtney Flaherty
December 26th 2025
A woman.

Advice for Patients Newly Diagnosed With Lung Cancer

ByPatricia I. Moreno
December 26th 2025
Image of ribbons.

Omitting Sentinel Lymph Node Biopsy Safe in Older Breast Cancer

ByGina Mauro
December 25th 2025
Advertisement
Advertisement

Trending on CURE

1

Top 5 Breast Cancer Updates From the 2025 San Antonio Breast Cancer Symposium

2

Advice for Patients Newly Diagnosed With Multiple Myeloma

3

A Five-Time Cancer Survivor’s Advice for Patients

4

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

5

Omitting Sentinel Lymph Node Biopsy Safe in Older Breast Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.